Since we first opened our doors in 1975, Fred Hutch’s reach has grown to span the world. In addition to our main Seattle campus, we have facilities in Uganda and South Africa. And no matter which side of the ocean we find ourselves, we’re united by a common goal: to detect, understand and prevent cancer and other diseases.
Our 15-acre campus, set on a lake in the heart of Seattle, anchors the city’s burgeoning biotech corridor. More than 3,500 people work in our state-of-the-art facilities, which were designed with flexibility, collaboration and sustainability in mind. Outdoors, our many courtyards and green spaces invite conversation and reflection.
The world-class UCI-Fred Hutch Cancer Centre in Kampala is the cornerstone of our global oncology work. Opened in 2015, the three-story, 25,000-square-foot facility can serve up to 16,000 patients a year. In its labs, researchers and physicians from around the world focus on infection-related cancers and other diseases.
Our lab in Cape Town is one of the most advanced research facilities on the African continent. The 10,000-square-foot facility opened in 2013 and is helping to accelerate groundbreaking efforts by the Fred Hutch–led HIV Vaccine Trials Network to develop an HIV vaccine.